Indications/Uses
Prophylaxis to prevent bleeding or reduce frequency of bleeding episodes in adults & childn w/ hemophilia A (congenital factor VIII deficiency) w/ or w/o factor VIII inhibitors.
Dosage/Direction for Use
SC Loading dose: 3 mg/kg once wkly for the 1st 4 wk followed by maintenance dose from wk 5 of either 1.5 mg/kg once wkly or 3 mg/kg every 2 wk or 6 mg/kg every 4 wk.
Contraindications
Hypersensitivity.
Special Precautions
Monitor for the development of TMA &/or thromboembolism when administering aPCC. Discontinue bypassing agents the day before starting therapy. Hepatic & renal impairment. Pregnancy & lactation. Childn. Elderly.
Adverse Reactions
Inj site reactions; headache; arthralgia. Pyrexia; diarrhea; myalgia.
MedsGo Class
Haemostatics
Features
Brand
Hemlibra
Full Details
Dosage Strength
105 mg / 0.7 ml
Drug Ingredients
- Emicizumab
Drug Packaging
Solution for Injection (S.C.) 3ml x 1's
Generic Name
Emicizumab
Dosage Form
Solution For Injection (S.C.)
Registration Number
BR-1333
Drug Classification
Prescription Drug (RX)